NCT01274624 2018-12-19Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerOncolytics BiotechPhase 1 Completed36 enrolled
NCT02620423 2018-09-13Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic AdenocarcinomaOncolytics BiotechPhase 1 Completed11 enrolled